Haemonetics (HAE) Misses Q4 EPS by 5c; Guides FY16 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Haemonetics (HAE) Strong Sell Rating Removed at Off Wall Street
April 28, 2015 11:11 AM EDTHaemonetics's (NYSE: HAE) Strong Sell recommendation was removed at Off Wall Street after the company reported Q4 results and guidance, according to sources. Analysts noted FY16 guidance implies revenue and EPS growth.
... MoreBarrington Research Downgrades Haemonetics (HAE) to Market Perform
April 28, 2015 9:38 AM EDTBarrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform with a price target of $44.00. The change follows Q4 results and guidance.
Analyst Michael Petusky, "While we like many aspects of the Haemonetics story, particularly longer term, we do not see the... More
Haemonetics (HAE) PT Lifted at Jefferies Despite FX Hit
April 28, 2015 8:38 AM EDTJefferies analyst Anthony Petrone reiterated a Buy rating and bumped his price target on Haemonetics (NYSE: HAE) to $48.00 (from $45.00) following Q4 results. The analyst said while FX was unavoidable the underlying trends support a rebound in FY16.
Petrone commented, "HAE... More
